We investigated the role of early portal hypotensive pharmacotherapy in preventing the development of portal-systemic shunting in a portal hypertensive model of chronic murine schistosomiasis induced by infecting C3H mice with 60 cercariae of Schistosoma mansoni. Propranolol was administered in drinking water to 20 animals for a period of 6 wk at a dose of 10 mg.kg-1d-1, starting at 5 wk of sch...

There are few reports of portal vein thrombosis among living donor liver transplant donors and no published data on the management of this event. In this report, we present our experience in the diagnosis and management of this rare complication in two living donor liver transplantation donors who developed post-operative portal vein thrombosis. Both cases were successfully managed with intra-o...

BACKGROUND Several studies carried out to examine the growth of children with extra-hepatic portal vein obstruction and portal hypertension have reported a variety of findings. AIM To assess anthropometric indices in children with portal hypertension due to extra-hepatic portal vein obstruction and who were treated by endoscopic variceal sclerotherapy. METHODS Anthropometric data were obtai...

Portal hypertension can arise from any condition interfering with normal blood flow at any level within the portal system. Herein, we presented two uncommon cases of the portal hypertension and its treatment with brief literature review. A 71-year-old man who underwent right hemihepatectomy revealed a tumor recurrence adjacent to the inferior vena cava (IVC). After radiofrequency ablation (RFA)...

Context. Hepatic portal venous gas (HPVG) is a rare and sinister finding. Its mortality is associated with the underlying causative condition. When secondary to bowel ischaemia, mortality rates exceed 50%. Case Report. Two cases of HPVG are described. One case describes HPVG in association with gastric ischaemia, with complete resolution following conservative management. The second case descri...

Aim. The aim of the study was to assess the effects of valsartan, a new generation angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in cirrhosis. Methods. Eighty patients with cirrhosis and portal hypertension were divided in two groups as follows: group I 40 patients who received valsartan (Diovan) 80 mg /day for 7 days and group II 40 patients who ...

Dear Editor, I read with great interest the pictorial essay entitled “Cross-sectional imaging of congenital and acquired abnormalities of the portal venous system” by Özbayrak and Tatlı in November-December 2016 issue of Diagnostic and Interventional Radiology (1). The authors are to be congratulated for their effort on giving detailed information about the abnormalities of the portal venous sy...

BACKGROUND Patient portals can improve patient communication with providers, provide patients with greater health information access, and help improve patient decision making, if they are used. Because research on factors facilitating and limiting patient portal utilization has not been conceptually based, no leverage points have been indicated for improving utilization. OBJECTIVE The primary...

This article investigates the evolution of two different types of Web portals, one in Bangladesh and the other in Australia. The initial data collection was conducted in the early 2000s and revisited in 2009. The idea of a Web portal is not new, but in the last few years the portal concept has gained considerably in importance as new types of portal are developed and new uses found for portal t...